Soaring Above Pediatric
Type 2 Diabetes
SURPASS-PEDS: A Clinical Research Study for Children and Teens
We all want the best for our children, especially when it comes to their health. If your child has type 2 diabetes, they may qualify to participate in a clinical research study evaluating a potential treatment for this condition.
Together, we can find answers for children and teens living with type 2 diabetes.
Join the SURPASS-PEDS Study today.
Your child may be able to participate in the SURPASS-PEDS Study if they:
01
Are 10 to 17
years old
02
Have been diagnosed with
type 2 diabetes
03
Are currently being treated with diet, exercise, and metformin or basal insulin, or both medications
The investigational medication (a drug that has not been approved for general use by a country’s drug regulatory agency) being evaluated in this study is an injection delivered under the skin using a small needle.
Participants will receive all study-related care at no cost.
*An investigational medication is a drug that has not been approved for general use by a country’s drug regulatory agency.
About Pediatric Type 2 Diabetes (T2D)
- Pediatric T2D is a more aggressive disease than in adults with more rapid disease progression and onset of complications.1
- The average age of onset T2D in youth is 13 years old.2
- Once rare, T2D is becoming more common in children affected by obesity.
[1] TODAY Study Group. “Long-term complications in youth-onset type 2 diabetes.” New England Journal of Medicine 385.5 (2021): 416-426.
